TY  - GEN
AU  - Raposeiras-Roubín, Sergio
AU  - Núñez-Gil, Iván J
AU  - Jamhour, Karim
AU  - Abu-Assi, Emad
AU  - Conty, David Aritza
AU  - Vedia, Oscar
AU  - Almendro-Delia, Manuel
AU  - Sionis, Alessandro
AU  - Martin-Garcia, Agustin C
AU  - Corbí-Pascual, Miguel
AU  - Martínez-Sellés, Manuel
AU  - Uribarri, Aitor
AU  - Guillén, Marta
AU  - Acuña, José María García
AU  - País, Javier Lopez
AU  - Blanco, Emilia
AU  - Linares Vicente, José A
AU  - Flecha, Alejandro Sánchez Grande
AU  - Andrés, Mireia
AU  - Pérez-Castellanos, Alberto
AU  - Alonso, Joaquín
AU  - Rosselló, Xavier
AU  - Romo, Andrés Iñiguez
AU  - Feltes, Gisela
PY  - 2023
DO  - 10.1016/j.repc.2022.02.010
UR  - http://hdl.handle.net/20.500.12105/16451
AB  - Background: No evidence-based therapy has yet been established for Takotsubo syndrome (TTS). Given the putative harmful effects of catecholamines in patients with TTS, beta-blockers may potentially decrease the intensity of the detrimental cardiac...
LA  - eng
PB  - Elsevier
KW  - Takotsubo Cardiomyopathy
KW  - Humans
KW  - Aftercare
KW  - Cohort Studies
KW  - Patient Discharge
KW  - Prognosis
KW  - Registries
TI  - Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry
TY  - research article
ER  -